CAS: 754954-71-7 - (2R,4R,5R,6R)-5-acetamido-2-[[(2S,3S,4R,5S,6S)-5-acetamido-3-hydroxy-6-(4-nitrophenoxy)-4-[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]methoxy]-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]tetrahydropyra
Fórmula:C31H45N3O21
InChI:InChI=1/C31H45N3O21/c1-11(37)32-19-15(39)7-31(30(46)47,55-27(19)21(41)16(40)8-35)50-10-18-23(43)26(54-29-25(45)24(44)22(42)17(9-36)52-29)20(33-12(2)38)28(53-18)51-14-5-3-13(4-6-14)34(48)49/h3-6,15-29,35-36,39-45H,7-10H2,1-2H3,(H,32,37)(H,33,38)(H,46,47)/t15-,16-,17+,18+,19-,20+,21-,22+,23-,24+,25+,26-,27-,28-,29+,31-/m1/s1
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
Galβ(1-3)[neu5acα(2-6)]GlcNAc-β-PNP REF: 3D-EFB95471CAS: 754954-71-7 | Min. 95% | A consultar | Ter 21 Jan 25 |
Galβ(1-3)[neu5acα(2-6)]GlcNAc-β-PNP
Ref: 3D-EFB95471
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar |